Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 1
2001 1
2003 1
2004 1
2014 1
2016 1
2017 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

9 results

Results by year

Filters applied: . Clear all
Page 1
The pathogenesis of Graves' disease.
Gossage AA, Munro DS. Gossage AA, et al. Clin Endocrinol Metab. 1985 May;14(2):299-330. doi: 10.1016/s0300-595x(85)80036-0. Clin Endocrinol Metab. 1985. PMID: 2866051
The level of immunoglobulin stimulatory activity can be used for prediction of the likelihood of neonatal Graves' disease and of recurrence of disease after cessation of treatment with antithyroid drugs. ...
The level of immunoglobulin stimulatory activity can be used for prediction of the likelihood of neonatal Graves' disease …
Follow-up of newborns of mothers with Graves' disease.
Levy-Shraga Y, Tamir-Hostovsky L, Boyko V, Lerner-Geva L, Pinhas-Hamiel O. Levy-Shraga Y, et al. Thyroid. 2014 Jun;24(6):1032-9. doi: 10.1089/thy.2013.0489. Epub 2014 Mar 17. Thyroid. 2014. PMID: 24472020
BACKGROUND: Overt neonatal Graves' disease is rare, but may be severe, even life threatening, with deleterious effects on neural development. ...RESULTS: Ninety-six neonates were included in the study (49 males), with a total of 320 measurements of thyroid fu …
BACKGROUND: Overt neonatal Graves' disease is rare, but may be severe, even life threatening, with deleterious effects …
The use of oral radiographic contrast agents in the management of hyperthyroidism.
Fontanilla JC, Schneider AB, Sarne DH. Fontanilla JC, et al. Thyroid. 2001 Jun;11(6):561-7. doi: 10.1089/105072501750302868. Thyroid. 2001. PMID: 11442003 Review.
However, these agents may be especially useful in treating thyrotoxic patients preoperatively, in neonatal Graves' disease, in massive levothyroxine ingestion, and when other conventional antithyroid drugs are unsuccessful or contraindicated....
However, these agents may be especially useful in treating thyrotoxic patients preoperatively, in neonatal Graves' disease …
Follow-up of newborns with elevated screening T4 concentrations.
Lafranchi SH, Snyder DB, Sesser DE, Skeels MR, Singh N, Brent GA, Nelson JC. Lafranchi SH, et al. J Pediatr. 2003 Sep;143(3):296-301. doi: 10.1067/S0022-3476(03)00184-7. J Pediatr. 2003. PMID: 14517508
Sequence analysis revealed a point mutation in the thyroid hormone receptor-beta gene in one infant with thyroid hormone resistance; no mutation was identified in the other infant. CONCLUSIONS: Although neonatal Graves' disease occurs in approximately 1 in 25 …
Sequence analysis revealed a point mutation in the thyroid hormone receptor-beta gene in one infant with thyroid hormone resistance; no muta …
Clinical experience with a human thyroid cell bioassay for thyroid-stimulating immunoglobulin.
Rapoport B, Greenspan FS, Filetti S, Pepitone M. Rapoport B, et al. J Clin Endocrinol Metab. 1984 Feb;58(2):332-8. doi: 10.1210/jcem-58-2-332. J Clin Endocrinol Metab. 1984. PMID: 6141176
Prenatal TSI activity tended to be higher in mothers of infants who developed neonatal Graves' disease than in at-risk mothers who delivered normal infants. ...
Prenatal TSI activity tended to be higher in mothers of infants who developed neonatal Graves' disease than in at-risk …